A recent Nature article on novel GLP-1 therapies underscores a truth few key opinion leaders in medicine like to focus on: Even the most clinically impactful pharmaceutical accomplishments carry ...

For many Americans struggling to lose weight, powerful new medications are changing the game. With roughly 40% of U.S. adults living with obesity, according to the Centers for Disease Control ...

CytomX Therapeutics, Inc. upgraded to speculative Buy on Varseta-M mCRC data. Click for this updated look at CTMX stock and see why I am now bullish.

The AHA has published a scientific statement regarding the screening, diagnosis, and management of hypertriglyceridemia in pediatric patients.